Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling

• Ingrid E. H. Kremer ,

  * E-mail: i.kremer@maastrichtuniversity.nl

  Affiliation Department of Health Services Research, CAPHRI School of Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands

  ⨯
• Silvia M. A. A. Evers ,

  Contributed equally to this work with: Silvia M. A. A. Evers, Peter J. Jongen, Mickaël Hiligsmann

  Affiliations Department of Health Services Research, CAPHRI School of Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands, Public Mental Health, Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands

  ⨯
• Peter J. Jongen ,

  Contributed equally to this work with: Silvia M. A. A. Evers, Peter J. Jongen, Mickaël Hiligsmann

  Affiliations MS4 Research Institute, Nijmegen, The Netherlands, Department of Community & Occupational Medicine, University Medical Centre Groningen, Groningen, The Netherlands

  ⨯
• Trudy van der Weijden ,

  ¶‡ These authors also contributed equally to this work.

  Affiliation Department of Family Medicine, CAPHRI School of Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands

  ⨯
• Ilona van de Kolk ,

  ¶‡ These authors also contributed equally to this work.

  Affiliation Department of Health Promotion, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands

  ⨯
• Mickaël Hiligsmann

  Contributed equally to this work with: Silvia M. A. A. Evers, Peter J. Jongen, Mickaël Hiligsmann

  Affiliation Department of Health Services Research, CAPHRI School of Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands

  ⨯